Jane Street
IMCR icon

Jane Street’s Immunocore IMCR Stock Holding History

Jane Street’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-59,200
Closed -$1.78M – 12299
2026
Q1 		$1.78M Buy
59,200
+37,500
+173% +$1.21M ﹤0.01% 5316
2025
Q4 		$753K Buy
+21,700
New +$766K ﹤0.01% 6775
2025
Q1 		– Sell
-11,400
Closed -$336K – 9967
2024
Q4 		$336K Sell
11,400
-46,400
-80% -$1.47M ﹤0.01% 7547
2024
Q3 		$1.8M Sell
57,800
-54,400
-48% -$1.98M ﹤0.01% 4704
2024
Q2 		$3.8M Sell
112,200
-57,000
-34% -$2.91M ﹤0.01% 3405
2024
Q1 		$11M Buy
169,200
+88,500
+110% +$6.07M ﹤0.01% 1727
2023
Q4 		$5.51M Buy
80,700
+56,200
+229% +$2.92M ﹤0.01% 2714
2023
Q3 		$1.27M Sell
24,500
-86,000
-78% -$5.09M ﹤0.01% 4797
2023
Q2 		$6.63M Buy
110,500
+700
+0.6% +$40K ﹤0.01% 2373
2023
Q1 		$5.43M Buy
+109,800
New +$6.17M ﹤0.01% 2334

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street's IMCR Position: Q2 2026 in Review

Jane Street increased its Immunocore (IMCR) stake by 14% in Q2 2026, buying an estimated $857K and bringing the position to 233,348 shares worth $7.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

Jane Street first reported a position in IMCR in Q2 2022 and has held it in 15 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Jane Street held 233,348 shares of Immunocore worth $7.41M as of Q2 2026.
  • Jane Street bought 28,980 Immunocore shares in Q2 2026, an estimated $857K.
  • Immunocore made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #3194 holding.
  • Jane Street first reported a position in Immunocore in Q2 2022 and has held it in 15 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.